Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Yardeni

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Antiviral Research|June 28, 2020
Modeling based response guided therapy in subjects with recent hepatitis C infectionEvan Gorstein, Marianne Martinello, Alexander Churkin, et al.
Hepatology (Baltimore, Md.)|February 21, 2023
Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trialOhad Etzion, Saeed Hamid, Yoav Lurie, et al.
Scientific Reports|October 21, 2020
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot studyOhad Etzion, Harel Dahari, David Yardeni, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Antiviral Research|June 28, 2020
Modeling based response guided therapy in subjects with recent hepatitis C infectionEvan Gorstein, Marianne Martinello, Alexander Churkin, et al.
Hepatology (Baltimore, Md.)|February 21, 2023
Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trialOhad Etzion, Saeed Hamid, Yoav Lurie, et al.
Scientific Reports|October 21, 2020
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot studyOhad Etzion, Harel Dahari, David Yardeni, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Pageof 3